TNFRSF10B and colorectal carcinoma: In agreement with earlier studies, we have also observed a progressive increase in expression of TRAIL and its receptors: TRAIL-R1 and TRAIL-R2 in colorectal carcinoma and noted a strong association of TRAIL -R1 or TRAIL-R2 expression with differentiation and an early stage.